Medtronic · 1 month ago
Senior Strategic Therapy Manager (Brain) - NM - Fridley, MN (Onsite)
Fridley, Minnesota, United States of America
Full-time
Onsite
Senior Level
$162K/yr - $242K/yr
5+ years expMedtronic is a global leader in healthcare technology, dedicated to alleviating pain and restoring health. The Senior Strategic Therapy Manager will lead the clinical evidence strategy, driving therapy innovation and access through cross-functional collaboration and the integration of AI and real-world evidence.
Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical Device
Responsibilities
Translate business and therapy strategies into clinical evidence plans to enable clinical insights which drive evidence generation
Own the development and lifecycle of integrated evidence roadmaps
Drive upstream and downstream alignment with R&D, Regulatory, HEOR, Marketing, and Clinical Affairs
Identify and apply real-world datasets (EMR, claims, registries) and AI/ML tools to enhance clinical strategy
Collaborate with Data Science to explore digital biomarkers and AI-enabled clinical insights
Guide integration of digital health tools into study design or strategy
Support cross-functional core teams with clinical strategy expertise from concept to post-market
Monitor progress, resolve risks, and adapt plans based on closed study insights and market feedback
Review and prioritize External Research Program (ERP) and Collaborative Research Studies
Partner with key opinion leaders and scientific advisors to validate strategy direction
Collaborate with Medical Affairs and publication teams to drive timely, impactful dissemination
Ensure regional evidence needs are captured and incorporated into global strategy
Qualification
Required
Bachelor's degree and 7+ years of clinical research, strategy, or program management experience OR
Advanced degree with 5+ years of clinical research, strategy, or program management experience
Requires comprehensive management expertise and the ability to lead project teams within a department
Preferred
Master's degree (MS, MPH, MBA) or PhD in life sciences, engineering, or public health
At least 1 year of leadership experience (e.g., leading programs, workstreams, or cross-functional teams)
Experience in a healthcare environment, preferably within medical devices or regulated clinical research
Knowledge of neuromodulation, pelvic health, pain, or neuroscience therapy areas
Strong familiarity with real-world evidence (RWE), AI/ML applications, or digital health
Experience influencing upstream pipeline and downstream reimbursement/market access strategy
PMP certification or formal project/program management training
Excellent stakeholder communication and scientific writing skills
Benefits
Health, Dental and vision insurance
Health Savings Account
Healthcare Flexible Spending Account
Life insurance
Long-term disability leave
Dependent daycare spending account
Tuition assistance/reimbursement
Simple Steps (global well-being program)
Incentive plans
401(k) plan plus employer contribution and match
Short-term disability
Paid time off
Paid holidays
Employee Stock Purchase Plan
Employee Assistance Program
Non-qualified Retirement Plan Supplement (subject to IRS earning minimums)
Capital Accumulation Plan (available to Vice Presidents and above, or subject to IRS earning minimums)
Company
Medtronic
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
10001+ employees
H1B Sponsorship
Medtronic has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (349)
2024 (387)
2023 (291)
2022 (310)
2021 (300)
2020 (261)
Funding
Current Stage
Public CompanyTotal Funding
$18.16BKey Investors
NHS EnglandBlackstone Life SciencesTrade Capital Funding
2025-09-15Post Ipo Debt· $1.76B
2024-05-29Post Ipo Debt· $3.24B
2023-03-23Post Ipo Debt· $2B
Leadership Team
Geoffrey Martha
CEO and Chairman Of The Board Of Directors
Linnea Burman
SVP & President, Neurovascular
Recent News
BioWorld Financial Watch
2026-01-25
Company data provided by crunchbase